Summary & Overview
CPT 33271: Subcutaneous Implantable Defibrillator Electrode Insertion
CPT code 33271 denotes the subcutaneous implantation of an implantable defibrillator electrode into the heart to treat life‑threatening cardiac dysrhythmias. This operative cardiac procedure is clinically significant because it addresses ventricular arrhythmias that can lead to sudden cardiac arrest; utilization patterns and coverage policies for device implantation have material implications for clinical access and hospital resource use nationwide. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the clinical context for 33271, the typical sites of service, and payer coverage considerations. The publication summarizes common billing modifiers associated with surgical and device procedures, highlights typical service line placement (cardiac electrophysiology/device implantation), and outlines where further documentation and coding attention are commonly required. The content also points to benchmark topics and policy updates relevant to device implantation claims, including prior authorization trends and medical necessity determinations. Data not available in the input is noted where applicable, and the piece is written for a national audience focused on coding accuracy, billing workflow, and payer policy implications for implantable defibrillator electrode insertion.
Billing Code Overview
CPT code 33271 describes the insertion of a subcutaneous implantable defibrillator electrode into the patient’s heart. This procedure is performed to treat life‑threatening cardiac dysrhythmias that cause irregular heartbeats.
-
Service type: Invasive cardiac device implantation procedure
-
Typical site of service: Hospital operating room or cardiac catheterization/procedure lab
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with ischemic cardiomyopathy and a history of ventricular tachycardia is evaluated for prevention of sudden cardiac death. The patient reports episodes of syncope and documented sustained ventricular tachycardia on telemetry despite optimized medical therapy. After pre-procedure evaluation including transthoracic echocardiography, device interrogation (if prior devices exist), and assessment of vascular access and infection risk, the electrophysiology team schedules implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD). The procedure is performed in a cardiac electrophysiology laboratory or hybrid operating room under monitored anesthesia care or general anesthesia. The provider creates subcutaneous pockets and tunnels the electrode along the left lateral chest/western sternum configuration, verifies sensing and defibrillation thresholds, programs initial settings, and closes wounds. Post-procedure, the patient is observed for hemodynamic stability, device function, and wound complications before discharge with follow-up arranged in the device clinic for interrogation and programming adjustments.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no other modifier applies and services are submitted without special circumstances. |
11 |